Association of Glycated Hemoglobin Levels with Amputation Outcomes in Patients with Diabetic Foot Ulcers: A Cross-Sectional Study in Southern Iran (2023–2024)
DOI:
https://doi.org/10.31661/gmj.v14i.3967Keywords:
Diabetes Mellitus Type 2; Diabetic Foot; Hemoglobin A Glycosylated; AmputationAbstract
Background: Diabetic foot ulcer (DFU) is the most serious consequence of type 2 diabetes mellitus (T2DM). Glycated hemoglobin (HbA1c) acts as a marker of long-term glycemic control, but its prognostic value in predicting the severity in DFU patients remains undefined. This study aims to investigate the association between HbA1c levels and lower limb amputation risk at various anatomical levels in patients with DFU. Materials and Methods: This cross-sectional analytical study included 446 patients with T2DM and DFU admitted to Namazi Hospital, Shiraz, Iran, between February 2023 and January 2024. Patients were categorized into four groups based on the amputation level: above-knee, below-knee, foot/midfoot/forefoot, and toe/finger. HbA1c was measured and categorized into three groups (7–7.9%, 8–8.9%, and ≥9%). Univariate and multinomial logistic regression analyses were performed using the above-knee amputation group as the reference. Statistical analysis was conducted in R (v4.4.1), with significance set at P < 0.05. Result: Elevated HbA1c levels were significantly associated with increased odds of below-knee and foot amputations compared to above-knee amputation (OR = 6.27, P = 0.023 and OR = 8.16, P = 0.036, respectively, for HbA1c 8–8.9%). Similar associations were observed for HbA1c ≥9%. Additionally, patients who underwent less extensive amputations (i.e., foot and finger) tended to be younger and had shorter hospital stays compared to those who underwent above-knee amputations. Lower triglyceride levels were also associated with finger amputation (OR = 0.99, p = 0.031). These comparisons were made within all patients which had diabetic foot ulcers. Conclusion: Higher HbA1c levels are significantly associated with more distal amputation levels in patients with DFU. Patient characteristics such as younger age, shorter hospitalization, and lower triglyceride levels were more common among those undergoing less extensive amputations. These findings highlight the need for early glycemic control in DFU patients at risk of limb loss.
References
Barman N, Islam ABMMK, Haque MA. Association between adverse childhood experiences and type 2 diabetes mellitus in later life: A case-control study. PLOS Glob Public Health. 2024;4(6):e0002715.
https://doi.org/10.1371/journal.pgph.0002715
PMid:38917185 PMCid:PMC11198900
Moore Z, Avsar P, Wilson P, Mairghani M, O'Connor T, Nugent L et al. Diabetic foot ulcers: treatment overview and cost considerations. J Wound Care. 2021;30(10):786-91.
https://doi.org/10.12968/jowc.2021.30.10.786
PMid:34644133
Rodrigues BT, Vangaveti VN, Urkude R, Biros E, Malabu UH. Prevalence and risk factors of lower limb amputations in patients with diabetic foot ulcers: A systematic review and meta-analysis. Diabetes Metab Syndr. 2022;16(2):102397.
https://doi.org/10.1016/j.dsx.2022.102397
PMid:35085918
Anbarasi LJ, Jawahar M, Jayakumari RB, Narendra M, Ravi V, Neeraja R. An overview of current developments and methods for identifying diabetic foot ulcers: A survey. WIREs Data Min Knowl Discov. 2024;14(6):e1562.
https://doi.org/10.1002/widm.1562
Ran Q, Xu W, Zhao X, Sun H, Liu L, Luo Y. Risk factors for malnutrition in patients with diabetic foot ulcer and its association with prolonged length of hospitalization. Nutr Diabetes. 2024;14(1):26.
https://doi.org/10.1038/s41387-024-00290-6
PMid:38755177 PMCid:PMC11099008
Alrubaiee GG. Prevalence of chronic diabetic complications and associated risk factors among follow-up diabetic patients: estimates from a referral national diabetes center in Yemen. BMC Endocr Disord. 2025;25(1):68.
https://doi.org/10.1186/s12902-025-01893-5
PMid:40082878 PMCid:PMC11907894
Dawi J, Tumanyan K, Tomas K, Misakyan Y, Gargaloyan A, Gonzalez E, Hammi M, Tomas S, Venketaraman V. Diabetic Foot Ulcers: Pathophysiology, Immune Dysregulation, and Emerging Therapeutic Strategies. Biomedicines. 2025 Apr 29;13(5):1076.
https://doi.org/10.3390/biomedicines13051076
PMid:40426903 PMCid:PMC12109115
Sato Imuro SE, Sabharwal A, Bevier W, Kerr D. Evaluating HbA1c-to-average glucose conversion with patient-specific kinetic models for diverse populations. Sci Rep. 2024;14(1):22098.
https://doi.org/10.1038/s41598-024-72837-7
PMid:39333162 PMCid:PMC11437029
Yazdanpanah L, Shahbazian H, Hesam S, Ahmadi B, Zamani AM. Two-year incidence and risk factors of diabetic foot ulcer: second phase report of Ahvaz diabetic foot cohort (ADFC) study. BMC Endocr Disord. 2024;24(1):46.
https://doi.org/10.1186/s12902-024-01572-x
PMid:38622562 PMCid:PMC11017491
Swaminathan N, Awuah WA, Bharadwaj HR, Roy S, Ferreira T, Adebusoye FT et al. Early intervention and care for Diabetic Foot Ulcers in Low and Middle Income Countries: Addressing challenges and exploring future strategies: A narrative review. Health Sci Rep. 2024;7(5):e2075.
https://doi.org/10.1002/hsr2.2075
PMid:38690005 PMCid:PMC11058085
Bikramjit P, Raveender N, Sudipta P. The importance of HbA1C and erythrocyte sedimentation rate as prognostic factors in predicting the outcome of diabetic foot ulcer disease. Int J Adv Med. 2017;4(1):137-42.
https://doi.org/10.18203/2349-3933.ijam20170097
Armstrong David G, Boulton Andrew JM, Bus Sicco A. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376(24):2367-75.
https://doi.org/10.1056/NEJMra1615439
PMid:28614678
Zechmeister B, Fischer A, Eidizadeh A. Comparing a Direct Whole Blood Enzymatic Assay With High-Performance Liquid Chromatography for HbA1c Measurement. J Diabetes Sci Technol. 2023;18(1):244-6.
https://doi.org/10.1177/19322968231205842
PMid:37897243 PMCid:PMC10899854
Akyüz S, Mutlu ABB, Güven HE, Başak AM, Yılmaz KB. Elevated HbA1c level associated with disease severity and surgical extension in diabetic foot patients. Ulus Travma Acil Cerrahi Derg. 2023;29(9):1013.
https://doi.org/10.14744/tjtes.2023.08939
PMid:37681727 PMCid:PMC10560815
Wan EYF, Yu EYT, Mak IL, Youn HM, Chan KS, Chan EWY et al. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study. BMJ Open Diabetes Res Care. 2023;11(1):e003075.
https://doi.org/10.1136/bmjdrc-2022-003075
PMid:36634978 PMCid:PMC9843200
Tong KPS, Green SJ, Ortiz J, Wu SC. Association between hemoglobin A1c, Vitamin C, and microbiome in diabetic foot ulcers and intact skin: A cross-sectional study. Health Sci Rep. 2022;5(5):e718.
https://doi.org/10.1002/hsr2.718
PMid:35949674 PMCid:PMC9350426
Negash W, Assefa T, Sahiledengle B, Tahir A, Regassa Z, Feleke Z et al. Prevalences of diabetic foot ulcer and foot self-care practice, and associated factors in adult patients with diabetes in south-east Ethiopia. J Int Med Res. 2022;50(10):03000605221129028.
https://doi.org/10.1177/03000605221129028
PMid:36224759 PMCid:PMC9561672
Fan Z, Liu Y, Xie H, Yang Q, Zhang G, Zhang P et al. Analysis of risk factors for foot ulcers in diabetes patients with neurovascular complications. BMC Public Health. 2025;25(1):792.
https://doi.org/10.1186/s12889-025-21639-1
PMid:40011841 PMCid:PMC11866585
McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care. 2022;46(1):209-21.
https://doi.org/10.2337/dci22-0043
PMid:36548709 PMCid:PMC9797649
Li ZQ, Zhang YP, Fu GF, Chen JF, Zheng QP, Xian XM et al. Evaluation of the Effectiveness of Diabetic Foot Ulcer Recurrence Risk Prediction Models: A Systematic Review. Iran J Public Health. 2025;54(1):24-35.
https://doi.org/10.18502/ijph.v54i1.17572
Klein KR, Buse JB. The trials and tribulations of determining HbA1c targets for diabetes mellitus. Nat Rev Endocrinol. 2020;16(12):717-30.
https://doi.org/10.1038/s41574-020-00425-6
PMid:33082551 PMCid:PMC11653296
Guo L, Xiao X. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition). Aging Med (Milton). 2024;7(1):5-51.
https://doi.org/10.1002/agm2.12294
PMid:38571669 PMCid:PMC10985780
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Galen Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.





